All Articles

Private equity firm Sagewind Capital's latest hire isn't just another suit. It's a strategic move revealing a much deeper trend in high-stakes GovTech.

SPYLT is not just selling protein milk; it's selling a calculated rebellion. A deep dive into the brand's aggressive strategy to dominate the CPG landscape.

A new AI system at Nashville's airport promises shorter lines and better security. We analyze the tech and the execution challenges behind the hype.

The National Fatherhood Initiative is moving beyond institutional training, packaging its proven curriculum into a book to directly empower millions of dads.

Almaden Country Day School secures a rare Orton-Gillingham accreditation, becoming a national leader and offering integrated, gold-standard dyslexia support.

Being Frenshe's launch at Ulta Beauty is more than a retail deal; it's a strategic play at the intersection of wellness tech, authentic branding, and mass-market retail.

As AI chatbots become the new front door to the internet, brands risk vanishing. Jasper's autonomous GEO Agent aims to control the narrative.

A new partnership between BMO's Blue Rewards and Dollarama offers major points on budget buys, signaling a strategic shift in Canada's loyalty program wars.

The beloved wildlife warrior is tackling a new habitat: the male bedroom. Is this a genuine wellness push or a masterful marketing ploy for better bedding?

With a $5.3 billion backlog and pipeline, Congruex brings in financial heavyweight Jim Stanley to navigate explosive growth and complex market pressures.

Ontario home insurance costs surged 6.2% to a $2,235 average, driven by climate risks. A new report reveals a stark North-South divide in affordability.

As remote production booms, a major security flaw has emerged. Backlight's Iconik now integrates Castlabs tech to protect media from the very first frame.

A new report shows Canada's Grocery Code has industry support, but deep-seated fear prevents suppliers from using it to challenge powerful retailers.

As autonomous AI agents reshape industry, a critical trust gap emerges. Digimarc aims to close it by embedding a verifiable 'birth certificate' into AI actions.

A new partnership between Innoviva and Dr. Reddy's aims to bring a vital antibiotic, XACDURO®, to regions where a deadly hospital infection is rampant.

BioAge Labs starts a Phase 2 trial for BGE-102, an oral drug targeting inflammation to reduce heart risk, a strategy that could redefine cardiovascular care.

SOLVE's new cohort analysis tool isn't just tech; it's a strategic move in the AI arms race to close the execution gap in fixed income investing.

The at-home beauty tech giant is betting on immersive, influencer-led wellness events to conquer the US market. Is this the future of brand building?

Langan's fourth Texas acquisition isn't just a purchase; it's a calculated move to dominate the state's booming engineering and development market.

Eli Lilly's Zepbound secures a landmark approval for sleep apnea, moving beyond weight loss to redefine chronic disease management and challenge competitors.